Impending rise in autoimmune issues linked to Covid vaccines discussed in research findings.
-
Research focuses on potential autoimmune response to spike protein in Covid vaccines. • 0:28
-
Study in Italy suggests a possible autoimmune explosion in 20% of vaccinated individuals. • 2:42
-
Evidence of thyroid dysfunction post Pfizer Covid vaccine aligns with ongoing research on autoimmunity. • 3:30
Potential increase in autoimmune diseases post-Covid vaccination, based on recent Japanese study.
-
Study on SARS-COV2 BNT162b2 mRNA vaccine’s impact on thyroid autoimmunity. • 3:49
-
Research suggests small individual risk but significant population impact. • 4:07
-
Japanese study linked Covid vaccine to increased risk of Graves disease. • 5:36
-
Calls for more proactive research on vaccine-related autoimmune risks. • 6:40
-
Criticism on delay in investigating vaccine side effects despite widespread rollout. • 7:01
Autoimmune response observed post-Covid vaccination, potential thyroid gland hyperactivity.
-
Study on 99 healthcare workers showed progressive rise in thyroid autoantibodies post-vaccination. • 7:21
-
Thyroid antibody levels increased over 12 months, indicating potential thyrotoxicosis and Graves disease. • 8:50
-
Autoantibody response paralleled by gradual fall in thyroid stimulating hormone, suggesting thyroid gland hyperactivity. • 9:11
-
Study in 2022 found no significant difference in autoimmune markers post-Pfizer vaccine, benefits outweigh risks. • 10:13
Study reveals potential autoimmune response to mRNA vaccines in healthcare workers.
-
Caution urged in interpreting ‘safe and effective’ claims without extensive research. • 11:00
-
Research suggests mRNA vaccines may trigger autoimmunity in up to 20% of recipients. • 11:22
-
Study showed significant rise in autoantibodies after 12 months post vaccination. • 12:27
-
Autoimmune response may affect both new and baseline populations post vaccination. • 13:08
-
Long-term studies are crucial to understand unintended consequences of interventions. • 13:31
-
Vaccine development typically takes 5 to 10 years to identify patterns and risks. • 13:53
-
Reassurances of vaccine safety may lack evidence without long-term research. • 14:13
Impending rise in autoimmune diseases due to Covid vaccination impact on population health service delivery.
-
Autoimmunity impact on population health service delivery is significant. • 14:33
-
Increase in autoimmune diseases leads to strain on healthcare resources. • 14:56
-
Understanding autoimmunity is crucial in addressing Covid-19 challenges. • 15:18
-
Autoimmunity likely to rise in population post Covid-19. • 16:01
-
Targeting research towards autoimmunity is essential for the future. • 16:22